Mast Cell–Targeting Therapies in Mast Cell Activation Syndromes

被引:0
作者
Vito Sabato
Michiel Beyens
Alessandro Toscano
Athina Van Gasse
Didier G. Ebo
机构
[1] University of Antwerp,Department of Immunology, Allergology, Rheumatology, The Infla
[2] University of Antwerp,Med Centre of Excellence, Faculty of Medicine and Health Sciences
[3] Antwerp University Hospital,Department of Paediatrics, The Infla
来源
Current Allergy and Asthma Reports | 2024年 / 24卷
关键词
Mast cell activation syndromes (MCAS); Tyrosine kinase inhibitors (TKIs); Bruton tyrosine kinase inhibitors (BTKIs); Anti-IgE; Siglecs;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:63 / 71
页数:8
相关论文
共 357 条
[1]  
Theoharides TC(2015)Mast cells, mastocytosis, and related disorders N Engl J Med 373 163-172
[2]  
Valent P(2022)Global classification of mast cell activation disorders: an ICD-10-CM-adjusted proposal of the ECNM-AIM consortium J Allergy Clin Immunol Pract 10 1941-1950
[3]  
Akin C(2021)Mast cell activation syndrome: is anaphylaxis part of the phenotype? A systematic review Curr Opin Allergy Clin Immunol 21 426-434
[4]  
Valent P(2023)Increased excretion of mast cell mediator metabolites during mast cell activation syndrome J Allergy Clin Immunol Pract 11 2542-2546
[5]  
Hartmann K(2019)Why the 20% + 2 tryptase formula is a diagnostic gold standard for severe systemic mast cell activation and mast cell activation syndrome Int Arch Allergy Immunol 180 44-51
[6]  
Bonadonna P(2022)Personalized management strategies in mast cell disorders: ECNM-AIM user’s guide for daily clinical practice J Allergy Clin Immunol Pract 10 1999-2012.e6
[7]  
Gulen T(2018)EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy Allergy 73 744-764
[8]  
Brockow K(2019)AAAAI Mast Cell Disorders Committee Work Group Report: mast cell activation syndrome (MCAS) diagnosis and management J Allergy Clin Immunol 144 883-896
[9]  
Alvarez-Twose I(1983)A double-blind cross-over study of the effect of ketotifen in urticaria pigmentosa Dermatologica 166 44-47
[10]  
Sabato V(1993)Comparison of azelastine and chlorpheniramine in the treatment of mastocytosis J Allergy Clin Immunol 92 520-526